My Vaccine Program (MVP) Combines Best-of-Breed Technologies to Address Consumer Engagement, Vaccine Hesitancy and Safety Surveillance Related to COVID-19

Sandra Garrett, CEO of
MediMergent states: “The
MVP engages directly with consumers and captures their attitudes and behaviors related to their health/disease and treatment, in order to improve outcomes. To address vaccine hesitancy, consumers need accurate information regarding the risks/benefits and how people “just like me”, with similar health profiles, react to the vaccine. The
MVP builds a supportive community, especially for the medically underserved and ethnic and racial minorities.”
“Deploying a library of over 250 learning modules, we invite patients to open a dialogue with a virtual healthcare expert”, says Virginia Pribanic, CEO of
MedRespond. “The platform anticipates questions using AI-based algorithms and delivers personalized, patient-centered responses. We explore vaccine hesitancy, validate patients’ concerns, and present a fact-based discussion supporting the patients’ decision making.”

Related Keywords

United States ,Allan Horlick ,Sandra Garrett ,My Vaccine Program ,World Evidence Company ,Conversational Technology ,Real World Evidence Company ,Virginia Pribanic ,Vaccine Program ,Business Wire ,Covid 19 ,Coronavirus ,Ovid 19 Pandemic ,Infectious Diseases ,Iseases And Conditions ,Health ,Ung Disease ,Technology ,Harmaceutical Manufacturing ,Ealth Care Industry ,Business ,Consumer Safety ,Consumer Affairs ,Mmunizations ,Public Health ,ஒன்றுபட்டது மாநிலங்களில் ,சாண்ட்ரா காரெட் ,தடுப்பூசி ப்ரோக்ர்யாம் ,வணிக கம்பி ,விட் ,விட் சர்வதேச பரவல் ,